Evidence map›Paper›PMID 37490193›Full record

ReviewCurrent oncology reports2023

Enhanced Recovery in Gynecologic Oncology Surgery-State of the Science.

Gregg Nelson

Erratum issued Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Current oncology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06655506 (Enhanced Recovery Protocols in Gynecological Cancer Patients), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06655506 recruitingnot on this mapstarted 2024, after this paper: background citation

Enhanced Recovery Protocols in Gynecological Cancer Patients: a Feasibility Study

Typeobservational_patient_registrySponsorNational and Kapodistrian University of AthensRan2024 to 2026Enrolled600ConditionsERAS, Gynecologic Cancer, Perioperative Complication, Postoperative PainArmsERAS group, Control group
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Gregg NelsonDepartment of Obstetrics & Gynecology, Cumming School of Medicine, University of Calgary, 1331 29 St NW, Calgary, Alberta, T2N 4N2, Canada. gregg.nelson@ahs.ca.ORCID 0000-0002-8177-1098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeof reviewThe purpose of this review is to describe the state of the science of enhanced recovery after surgery (ERAS) in gynecologic oncology. RECENT

findingsOver the last 5 years, there is mounting evidence supporting ERAS in gynecologic oncology surgery. Despite this, surveys have found suboptimal uptake of ERAS, and stakeholders have highlighted the difficulty of ERAS implementation as a major barrier. To address this, the core components required for a successful ERAS implementation program (protocol, ERAS team, audit system) are reviewed. ERAS developments specific to gynecologic oncology are also discussed, including same-day discharge initiatives for minimally invasive surgery, implications of telemedicine, and methods to increase uptake of ERAS in low- and middle-income countries. ERAS is a surgical quality improvement program with strong evidence supporting its effectiveness in gynecologic oncology. Efforts are required to address ERAS implementation barriers to increase uptake globally, especially in low-income settings.

Indexed as

Enhanced Recovery After SurgeryGenital Neoplasms, FemaleFemaleGynecologic Surgical ProceduresHumansLength of StayPerioperative CareQuality ImprovementEnhanced recovery after surgeryERASGynecologic cancerGynecologic oncologyPerioperative careSurgical quality improvement

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.